Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 47%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is well positioned for sustained growth in the near term as evident from its strong Q1 2026 results, including earnings upside on Specialty & Care as well as evident MLR strength. Additionally, the company's focus on expanding its PBM and specialty pharmacy services, along with new client wins and strategic exits from less profitable business lines, further support its positive outlook. The company's commitment to diversity and accessibility also adds to its appeal for sustainable-minded investors.

Bears say

Cigna Group is facing execution risk in predicting and managing medical cost trends and network contracting, as well as potential impact from regulatory changes on rebate economics. Additionally, a potential economic downturn could negatively affect the company's earnings growth trajectory. However, the company's strong PBM selling season and secured business wins suggest continued competitiveness in the market, leading to estimates being raised and a price target of $337. Despite exiting certain business lines and focusing on core areas, the potential risk and investment in scaling the remaining lines may outweigh the potential benefit. Furthermore, the company's efforts to incorporate sustainability into its strategy through its Cigna Connects platform may help address global challenges and positively impact the company's reputation and operations.

Cigna (CI) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 47% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 17 analysts, Cigna (CI) has a Buy consensus rating as of Jun 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $345, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $345, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.